tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Chemomab Therapeutics Ltd

CMMB
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
2.600USD
-0.090-3.35%
์ข…๊ฐ€ย 09-10 16:00๏ผˆET๏ผ‰
75.64M์‹œ๊ฐ€์ด์•ก
14.98P/E TTM
์žฅ์™ธ ๊ฑฐ๋ž˜ย ย (ET)0.000USD0.000

Chemomab Therapeutics Ltd

2.600
-0.090-3.35%
๊ฐœ์š”
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

CMMB ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Chemomab Therapeutics Ltd์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
75.64M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
14.98
์ฃผ๋‹น์ˆœ์ด์ต
0.17
์ˆ˜์ต
--
์ˆœ์ด์ต
-13.95M
ROE
-70.61%
ROA
-60.46%

Chemomab Therapeutics Ltd ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 19, 2026
EPS / ์˜ˆ์ƒ
--/-0.15
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
์žฌ๋ฌด ์ง€ํ‘œ
EPS
80.97%-0.27
61.81%-0.22
48.00%-0.24
64.55%-0.28
-39.95%-0.36
46.51%-0.15
56.14%-0.11
42.47%-0.20
97.79%-0.25
97.85%-0.27
97.77%-0.26
96.95%-0.35
---11.50
---12.68
---11.75
---11.30
----
----
----
----
----
----
----
----
----
----
----
----
----
----
์ˆœ์ด์ต
-5.25%-2.17M
46.64%-1.77M
36.79%-1.87M
49.99%-1.74M
43.35%-2.06M
14.09%-3.32M
13.29%-2.96M
14.65%-3.48M
54.44%-3.63M
55.81%-3.87M
58.69%-3.42M
49.49%-4.08M
-28.76%-7.97M
-71.49%-8.75M
-64.26%-8.27M
-172.24%-8.08M
-123.47%-6.19M
-199.53%-5.10M
-134.89%-5.04M
-142.48%-2.97M
----
----
----
----
----
----
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์˜์—… ์ด์ต
0.93%-2.24M
46.95%-1.85M
38.56%-1.97M
50.30%-1.84M
39.97%-2.26M
13.86%-3.49M
16.50%-3.21M
15.04%-3.71M
54.02%-3.77M
55.27%-4.05M
55.47%-3.85M
47.49%-4.37M
-31.04%-8.20M
-70.09%-9.05M
-72.01%-8.64M
-187.69%-8.32M
-127.17%-6.25M
-213.13%-5.32M
-125.49%-5.02M
-136.00%-2.89M
----
----
----
----
----
----
----
----
----
----
์ˆœ์ด์ต
-5.25%-2.17M
46.64%-1.77M
36.79%-1.87M
49.99%-1.74M
43.35%-2.06M
14.09%-3.32M
13.29%-2.96M
14.65%-3.48M
54.44%-3.63M
55.81%-3.87M
58.69%-3.42M
49.49%-4.08M
-28.76%-7.97M
-71.49%-8.75M
-64.26%-8.27M
-172.24%-8.08M
-123.47%-6.19M
-199.53%-5.10M
-134.89%-5.04M
-142.48%-2.97M
----
----
----
----
----
----
----
----
----
----
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
-6.19%9.96M
-4.20%11.47M
-16.30%13.43M
-40.05%11.93M
-21.11%10.61M
-28.86%11.98M
-23.24%16.04M
-11.06%19.89M
-51.43%13.46M
-50.15%16.84M
-49.93%20.90M
-54.10%22.37M
-49.47%27.70M
-43.08%33.78M
-33.42%41.74M
-26.00%48.73M
-20.35%54.83M
-0.31%59.34M
924.98%62.69M
791.20%65.84M
----
----
----
----
----
----
----
----
----
----
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
8.60%1.55M
-50.47%1.11M
-54.07%1.48M
-73.86%1.14M
-66.81%1.43M
-48.91%2.25M
-33.48%3.22M
-19.01%4.35M
-36.88%4.31M
-37.14%4.40M
-28.32%4.84M
-1.95%5.37M
55.33%6.83M
98.95%7.00M
154.68%6.75M
236.01%5.48M
103.52%4.39M
-24.06%3.52M
2.47%2.65M
-28.35%1.63M
----
----
----
----
----
----
----
----
----
----
์ด ์ž์‚ฐ
-8.01%10.24M
-7.89%11.81M
-18.58%13.81M
-40.81%12.37M
-23.48%11.13M
-28.82%12.82M
-23.42%16.96M
-10.77%20.90M
-49.59%14.54M
-48.56%18.01M
-48.56%22.15M
-53.37%23.42M
-48.83%28.85M
-42.56%35.01M
-33.08%43.06M
-25.54%50.22M
-20.05%56.38M
1.39%60.96M
941.48%64.35M
777.10%67.44M
----
----
----
----
----
----
----
----
----
----
๋ถ€์ฑ„ ์ด๊ณ„
8.60%1.55M
-54.12%1.11M
-56.87%1.48M
-75.17%1.14M
-68.63%1.43M
-48.14%2.43M
-33.51%3.43M
-14.81%4.58M
-33.52%4.56M
-33.73%4.68M
-24.65%5.15M
-3.93%5.38M
50.99%6.86M
89.76%7.06M
136.92%6.84M
190.20%5.59M
83.22%4.54M
-24.98%3.72M
10.95%2.89M
-17.54%1.93M
----
----
----
----
----
----
----
----
----
----
์ž๋ณธ ์ด๊ณ„
-10.45%8.69M
2.91%10.70M
-8.89%12.33M
-31.17%11.23M
-2.86%9.70M
-22.04%10.39M
-20.36%13.54M
-9.56%16.32M
-54.60%9.98M
-52.31%13.33M
-53.08%17.00M
-59.57%18.04M
-57.58%21.99M
-51.16%27.95M
-41.07%36.22M
-31.88%44.62M
-23.81%51.84M
3.76%57.24M
1618.37%61.47M
1124.29%65.51M
----
----
----
----
----
----
----
----
----
----
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
----
----
----
----
----
----
----
----
----
----
34.82%-3.72M
0.63%-5.22M
-31.31%-7.49M
-93.64%-7.19M
-97.06%-5.70M
-103.68%-5.25M
-1.68%-5.70M
-187.01%-3.71M
-71.24%-2.89M
-186.35%-2.58M
-542.27%-5.61M
32.41%-1.29M
71.42%-1.69M
74.31%-901.00K
77.70%-873.00K
38.73%-1.91M
---5.91M
---3.51M
---3.92M
---3.12M
์ˆœํˆฌ์ž
----
----
----
----
----
----
----
----
----
----
-81.56%1.72M
-34.29%3.99M
-347.13%-4.27M
505.88%14.43M
147.75%9.35M
221.48%6.07M
108.38%1.73M
119200.00%2.38M
-115282.35%-19.58M
-24900.00%-5.00M
-70944.83%-20.60M
80.00%-2.00K
-93.23%17.00K
92.16%-20.00K
-81.25%-29.00K
86.67%-10.00K
--251.00K
---255.00K
---16.00K
---75.00K
์ˆœ์žฌ๋ฌดํ™œ๋™
----
----
----
----
----
----
----
----
----
----
345.45%2.13M
-92.31%3.00K
6118.18%1.37M
--0.00
-972.84%-869.00K
154.17%39.00K
-99.84%22.00K
-100.00%0.00
-127.27%-81.00K
-112.81%-72.00K
329.70%13.43M
9459.80%47.80M
--297.00K
--562.00K
360.85%3.13M
-98.20%500.00K
--0.00
--0.00
---1.20M
--27.82M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Chemomab Therapeutics Ltd์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Chemomab Therapeutics Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 13.43M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -16.30์ž…๋‹ˆ๋‹ค.

Chemomab Therapeutics Ltd์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Chemomab Therapeutics Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Chemomab Therapeutics Ltd์˜ ์ด์ž์‚ฐ์€ 13.81M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -18.58์ž…๋‹ˆ๋‹ค.

Chemomab Therapeutics Ltd์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Chemomab Therapeutics Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Chemomab Therapeutics Ltd์˜ ์ด๋ถ€์ฑ„๋Š” 1.48M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -56.87์ž…๋‹ˆ๋‹ค.

Chemomab Therapeutics Ltd์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Chemomab Therapeutics Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Chemomab Therapeutics Ltd์˜ ์ด์ž๋ณธ์€ 12.33M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -8.89์ž…๋‹ˆ๋‹ค.

Chemomab Therapeutics Ltd์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Chemomab Therapeutics Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Chemomab Therapeutics Ltd์˜ ์ˆœ์˜์—…์†Œ๋“์€ -9.57M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 35.09์ž…๋‹ˆ๋‹ค.

Chemomab Therapeutics Ltd์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Chemomab Therapeutics Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Chemomab Therapeutics Ltd์˜ ์ˆœํˆฌ์ž๋Š” 5.39M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 134.65์ž…๋‹ˆ๋‹ค.

Chemomab Therapeutics Ltd์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Chemomab Therapeutics Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Chemomab Therapeutics Ltd์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 7.16M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -27.47์ž…๋‹ˆ๋‹ค.

Chemomab Therapeutics Ltd์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Chemomab Therapeutics Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -1.41์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 88.65์ž…๋‹ˆ๋‹ค.

Chemomab Therapeutics Ltd์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Chemomab Therapeutics Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -8.99M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 35.50์ž…๋‹ˆ๋‹ค.

Chemomab Therapeutics Ltd์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Chemomab Therapeutics Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -69.54์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 23.87์ž…๋‹ˆ๋‹ค.

Chemomab Therapeutics Ltd์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Chemomab Therapeutics Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -58.45์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 18.02์ž…๋‹ˆ๋‹ค.

Chemomab Therapeutics Ltd์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Chemomab Therapeutics Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -9.57M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 35.09์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ